BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22706535)

  • 21. Fludarabine: a review of its use in non-Hodgkin's lymphoma.
    Anderson VR; Perry CM
    Drugs; 2007; 67(11):1633-55. PubMed ID: 17661532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Secondary malignancies after successful primary treatment of malignant Hodgkin's lymphoma].
    Borchmann P; Behringer K; Josting A; Rueffer JU; Schnell R; Diehl V; Engert A; Kvasnicka HM; Thiele J
    Pathologe; 2006 Feb; 27(1):47-52. PubMed ID: 16369761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients.
    Niparuck P; Kanoksil W; Chuncharunee S; Boonsakan P; Ungkanont A; Angchaisuksiri P; Karntisaviwat K; Apilugsanachit A; Rerkamnuatchoke B; Jootar S; Nitiyanant P; Atichartakarn V
    Leuk Lymphoma; 2010 Nov; 51(11):2120-5. PubMed ID: 20846095
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chronic lymphatic leukemia and Hodgkin's disease].
    Calvo Villas J; Ramírez Sánchez M; Sicilia Guillén F
    Sangre (Barc); 1999 Oct; 44(5):393-4. PubMed ID: 10618924
    [No Abstract]   [Full Text] [Related]  

  • 25. [Low grade non-Hodgkin's lymphoma after combined therapy for Hodgkin's disease].
    Raya Sánchez JM; González Brito G; Hernández Nieto L; Brito Barroso ML; Alvarez Argüelles H; Jorge Hernández JA; Martín Herrera A
    Sangre (Barc); 1994 Dec; 39(6):461-4. PubMed ID: 7855699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma.
    Sambade C; Berglund M; Lagercrantz S; Sällström J; Reis RM; Enblad G; Glimelius B; Sundström C
    Int J Cancer; 2006 Feb; 118(3):555-63. PubMed ID: 16106419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus reactivation during fludarabine therapy in non-Hodgkin's lymphoma.
    Yavuz S; Paydas S; Disel U; Sahin B
    Leuk Lymphoma; 2003 Jul; 44(7):1249-50. PubMed ID: 12916882
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute tumor lysis syndrome complicating fludarabine treatment of prolymphocytic leukemia.
    Cannon LM; Spilove L; Rhodes R; Garfinkel H; Pezzimenti J
    Conn Med; 1993 Oct; 57(10):651-4. PubMed ID: 8275684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein barr virus hemophagocytic lymphohistiocytosis related to rituximab use and immunopathogenetic insights.
    Papageorgiou SG; Tsiodras S; Siakallis G; Bazani E; Spathis A; Poulakou G; Korkolopoulou P; Panayiotides I; Pappa V
    Pathol Res Pract; 2016 Dec; 212(12):1194-1198. PubMed ID: 28340951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.
    Carney DA; Westerman DA; Tam CS; Milner A; Prince HM; Kenealy M; Wolf M; Januszewicz EH; Ritchie D; Came N; Seymour JF
    Leukemia; 2010 Dec; 24(12):2056-62. PubMed ID: 20962860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteosarcoma of the mandible--second cancer in a case of Hodgkin's lymphoma post-chemotherapy.
    De S; Ghosh S; Mondal D; Sur PK
    J Cancer Res Ther; 2010; 6(3):336-8. PubMed ID: 21119269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
    Carella AM; Cavaliere M; Lerma E; Ferrara R; Tedeschi L; Romanelli A; Vinci M; Pinotti G; Lambelet P; Loni C; Verdiani S; De Stefano F; Valbonesi M; Corsetti MT
    J Clin Oncol; 2000 Dec; 18(23):3918-24. PubMed ID: 11099321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Classic Hodgkin's lymphoma in post-treatment hairy cell leukemia: report of a case].
    Chen DB; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):848-9. PubMed ID: 22336215
    [No Abstract]   [Full Text] [Related]  

  • 34. CD20-negative T-cell-rich B-cell lymphoma as a progression of a nodular lymphocyte-predominant Hodgkin's lymphoma treated with rituximab: a molecular analysis using laser capture microdissection.
    Pijuan L; Vicioso L; Bellosillo B; Ferrer MD; Baró T; Pedro C; Lloreta-Trull J; Munné A; Serrano S
    Am J Surg Pathol; 2005 Oct; 29(10):1399-403. PubMed ID: 16160485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune thrombocytopenia associated with the first cycle of fludarabine therapy in the treatment of relapsed non-Hodgkin's lymphoma.
    Churn M; Clough V
    Clin Oncol (R Coll Radiol); 2001; 13(4):273-5. PubMed ID: 11554624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
    Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
    Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and rapid dissemination of Merkel-cell carcinomatosis following therapy with fludarabine and rituximab for relapsing follicular lymphoma.
    Cohen Y; Amir G; Polliack A
    Eur J Haematol; 2002 Feb; 68(2):117-9. PubMed ID: 12061321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation.
    Waterman J; Rybicki L; Bolwell B; Copelan E; Pohlman B; Sweetenham J; Dean R; Sobecks R; Andresen S; Kalaycio M
    Bone Marrow Transplant; 2012 Apr; 47(4):488-93. PubMed ID: 21572461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
    Rysenga E; Linden MD; Carey JL; Ross CW; Schnitzer B; Sawdyk M; Maeda K
    Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.